GlassScriptPhysician profile
Adam Henry Kaufman
NPI 1609819085
$18,568.16
in general payments reported to CMS, 2019-2025
32 companies · $3,998 in 2025
The $3,998 reported for 2025 was more than what 93% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,049 · 2020: $544 · 2021: $1,599 · 2022: $1,303 · 2023: $1,637 · 2024: $1,439 · 2025: $3,998.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,386 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Education: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,386.04 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Education | $187.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $3,682.58 | 2019-2021 | |
| Alcon Vision LLC | $3,650.38 | 2019-2025 | Clareon, Centurion, Hydrus Microstent |
| Recordati_rare_diseases_inc. | $3,092.13 | 2019 | |
| Sight Sciences, INC. | $2,500.00 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Haag-Streit USA, INC. | $1,007.59 | 2021-2023 | |
| Biotissue Holdings INC. | $664.03 | 2022-2024 | |
| Glaukos Corporation | $547.87 | 2020-2023 | |
| Mallinckrodt Hospital Products INC. | $485.78 | 2022-2025 | Acthar |
| Johnson & Johnson Surgical Vision, INC. | $438.81 | 2019-2025 | Tecnis Simplicity, Tecnis Iol, Amo Phaco Needle |
| Sun Pharmaceutical Industries INC. | $256.20 | 2020-2025 | Cequa |
| Regeneron Healthcare Solutions, INC. | $219.97 | 2023-2025 | Eylea Hd, Eylea, Dupixent |
| Harrow Eye, LLC | $217.51 | 2024-2025 | Vevye |
| Allergan, INC. | $208.88 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $198.80 | 2019-2020 | |
| Dompe US, INC. | $185.04 | 2020-2025 | Oxervate |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $173.86 | 2022-2024 | Iolmaster 700, Forum |
| Abbvie INC. | $133.36 | 2022-2025 | |
| Integra Lifesciences Corporation | $126.74 | 2019 | |
| Horizon Therapeutics Plc | $120.93 | 2021 | |
| Mallinckrodt Enterprises LLC | $117.73 | 2019 | |
| Oyster Point Pharma, INC. | $86.41 | 2022-2024 | Tyrvaya |
| Rayner Intraocular Lenses Limited | $77.95 | 2025 | Rayner Cataract Set 1, Rayone Aspheric, Rayone Spheric |
| Ani Pharmaceuticals, INC. | $68.71 | 2024 | Purified Cortrophin Gel |
| Novartis Pharmaceuticals Corporation | $61.41 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $60.55 | 2022-2025 | Xiidra, Miebo |
| Astellas Pharma US INC | $47.02 | 2023 | |
| Kala Pharmaceuticals, INC. | $39.76 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $36.73 | 2024 | Xdemvy |
| Thea Pharma INC. | $18.78 | 2025 | Iyuzeh |
| Eyepoint US, INC. | $16.42 | 2019 | |
| Immunogen, INC. | $14.30 | 2023 | Elahere |
| Shire North American Group INC | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Kaufman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.